No cannabis companies splits investors squarely down the middle like Heritage Cannabis (CANN.C). Despite ongoing good news and deals with larger players, a sizable section of the legacy cannabis investing community has just never been able to get on board with the Canadian weedco – until this week.
Our Joseph Morton blew the trumpet on the news yesterday:
Alberta customers will soon have all seven of Heritage’s vape cartridge products including Pura Vida CBD 4:1 Honey Oil, and Indica, Sativa and Hybrid Honey Oil, as well as Purefarma’s Moon, Sun adn CBD Earth vapes. The company launched their Pura Vida and Purefarma product lines in September and met with excellent customer response in B.C, Manitoba and Saskatchewan, where the three are available, and across Canada from the Patient Choice platform.
And the investors, they did come.
To get to this place, where the trading volume on the stock is steadily increasing every day, Heritage has been putting in the work.
This is a newsflow like few others.
- Orders come in from Saskatchewan
- Strips deal forged with IntelGenx
- New products launched in BC
- Subsidiary gets oil sales license
- Closed acquisition of US-based Opticann
- Products land on Patients Choice sales platform
And that’s just since October.
The company did make a loss last quarter, what with COVID-19 impacting processes, but that net loss came in at $15k.
That’s right – a net loss of $15,000, or zero cents per common share, compared with a net loss of $4.2-million in Q3 2019.
At the end of Q3 2020, the company had cash and cash equivalents of $10.2-million, giving them a runway of approximately 56 years…
At a time when cannabis companies are still fighting the stigma of being risky money pits, Heritage Cannabis is finally starting to get the message through to people that it’s a low risk, fast growing, vertically integrated organization coming fast around the corner.
— Chris Parry
FULL DISCLOSURE: Heritage Cannabis is an Equity.Guru marketing client and we’re starting to think we ought to take a position.